| EQ-5D Utility score (mean ± SD, n) | EQ-VAS score (mean ± SD, n) | Change in EQ-5D Dimension level with limitation from baseline to 3-month (%) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Baseline | 3-month | Difference | p value* | Baseline | 3-month | Difference | p value* | Mobility | Self-care | Usual Activities | Pain/Discomfort | Depression/Anxiety | |
GRS Group | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
GRS Better | 0.58 ± 0.28 (20) | 0.76 ± 0.26 (20) | 0.18 ± 0.18 (20) | < 0.001 | 65.90 ± 18.13 (20) | 76.65 ± 14.00 (20) | 10.75 ± 15.33 (20) | 0.005 | − 15.0% (20) | − 15.0% (20) | − 15.0% (20) | − 40% (20) | − 20% (20) |
Effect size | Â | Â | 0.666 | Â | Â | Â | 0.664 | Â | Â | Â | Â | Â | Â |
GRS Same | 0.71 ± 0.23 (44) | 0.79 ± 0.17 (44) | 0.08 ± 0.17 (44) | 0.002 | 74.59 ± 15.22 (44) | 76.32 ± 11.54 (44) | 1.73 ± 12.60 (44) | 0.368 | − 9.1% (44) | − 2.3% (44) | − 2.3% (44) | − 13.6% (44) | 0% (44) |
Effect size | Â | Â | 0.396 | Â | Â | Â | 0.128 | Â | Â | Â | Â | Â | Â |
GRS Worse | 0.61 ± 0.27 (35) | 0.53 ± 0.30 (35) | − 0.08 ± 0.28 (35) | 0.092 | 67.37 ± 15.22 (35) | 62.43 ± 18.08 (35) | − 4.94 ± 18.31 (35) | 0.120 | 14.3% (35) | 2.9% (35) | 8.6% (35) | 22.9% (35) | 2.9% (35) |
Effect size |  |  | 0.280 |  |  |  | 0.296 |  | p  value# | ||||
 |  |  |  |  |  |  |  |  | < 0.001 | < 0.001 | < 0.001 | 0.021 | < 0.001 |
Overall | 0.65 ± 0.26 (99) | 0.69 ± 0.27 (99) | 0.04 ± 0.24 (99) | 0.074 | 70.28 ± 16.33 (99) | 71.47 ± 15.97 (99) | 1.19 ± 16.24 (99) | 0.467 | − 2.2% (99) | − 2.0% (99) | − 1.0% (99) | − 6.1% (99) | − 3.0% (99) |
Effect size | Â | Â | 0.151 | Â | Â | Â | 0.074 | Â | Â | Â | Â | Â | Â |
Mean GRS†|  |  | 0.589** |  |  |  | 0.495** |  |  |  |  |  |  |